Together, these findings underscore the intricate and context‐sensitive role of DKK3, delaying oncogenesis during early stages while paradoxically promoting tumor progression in later stages, suggesting that therapeutic targeting strategies should be approached with caution. Here, DKK3 is linked to neoplasm.